Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

Elanix Biotechnologies AG, DE000A0WMJQ4

Elanix Biotechnologies AG, DE000A0WMJQ4

03.10.2019 - 10:36:20

Elanix Biotechnologies AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

Elanix Biotechnologies AG hereby announces that the following financial reports shall be disclosed for the business year 2019:

Report: Financial report (half-year/Q2) Date of disclosure / German: June 30, 2019 Date of disclosure / English: June 30, 2019 German: http://elanixbiotechnologies.ch/financial-reports English: http://elanixbiotechnologies.ch/financial-reports

03.10.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: Elanix Biotechnologies AG c/o Frankfurt, Hanauer Landstrasse 291 B (BC GmbH) 60314 Frankfurt am Main

Germany Internet: www.elanixbiotechnologies.ch   End of News DGAP News Service

884965  03.10.2019 

@ dgap.de